The Avizakimab Biosimilar IL21 Antibody (AB10010) is a cutting-edge biologic designed for research involving the interleukin-21 (IL-21) pathway, a key player in immune function and autoimmune diseases. This antibody, developed as a biosimilar to the well-known Avizakimab, is highly specific and reacts with human IL-21 with high affinity, making it a valuable tool for studying the IL-21 signaling pathway.Raised in a state-of-the-art production facility, the Avizakimab Biosimilar IL21 Antibody has been rigorously validated for use in various immunoassays, including ELISA and flow cytometry.
Its ability to target and block IL-21 activity makes it an essential tool for researchers investigating the role of IL-21 in autoimmune disorders, inflammation, and cancer.By understanding the mechanisms of IL-21 and its impact on immune regulation, researchers can uncover new therapeutic targets and develop innovative treatments for a range of diseases. The Avizakimab Biosimilar Anti-IL21 Antibody opens up exciting possibilities for exploring the complex interplay between the immune system and disease pathogenesis, paving the way for novel therapeutic interventions.
Product Name:
Avizakimab Biosimilar (IL21) Antibody (HDBS0094)
Size:
100 ug
Product SKU:
HDBS0094
Target:
IL21
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BOS161721
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
